Drugmakers signed deals worth at least $18 billion in combined value on Monday, the first day of the healthcare industry's ...
Johnson & Johnson kicked off the J.P. Morgan Healthcare Conference on Monday with the $14.6 billion acquisition of Intra-Cellular Therapies.